[Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update]

Enferm Infecc Microbiol Clin. 2011 May;29(5):345-61. doi: 10.1016/j.eimc.2011.01.008. Epub 2011 Apr 2.
[Article in Spanish]

Abstract

These guidelines are an update of the recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) that were issued in 2004 (Enferm Infecc Microbiol Clin. 2004, 22:32-9) on the treatment of Invasive Candidiasis and infections produced by other yeasts. This 2010 update includes a comprehensive review of the new drugs that have appeared in recent years, as well as the levels of evidence for recommending them. These guidelines have been developed following the rules of the SEIMC by a working group composed of specialists in infectious diseases, clinical microbiology, critical care medicine, paediatrics and oncology-haematology. It provides a series of general recommendations regarding the management of invasive candidiasis and other yeast infections, as well as specific guidelines for prophylaxis and treatment, which have been divided into four sections: oncology-haematology, solid organ transplantation recipients, critical patients, and paediatric patients.

Publication types

  • English Abstract
  • Practice Guideline

MeSH terms

  • Adult
  • Candidiasis, Invasive / complications
  • Candidiasis, Invasive / drug therapy*
  • Child
  • Critical Illness
  • Hematologic Neoplasms / complications
  • Humans
  • Mycoses / complications
  • Mycoses / drug therapy
  • Organ Transplantation
  • Postoperative Complications / drug therapy